Novel motif:18: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:35, 9 September 2013
name: | motif18_CATCAG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050896 | response to stimulus | 4.095376e-68 |
GO:0006950 | response to stress | 9.940090e-46 |
GO:0065008 | regulation of biological quality | 3.002687e-42 |
GO:0032501 | multicellular organismal process | 7.491159e-41 |
GO:0051716 | cellular response to stimulus | 2.862437e-40 |
GO:0007154 | cell communication | 2.010922e-38 |
GO:0065007 | biological regulation | 3.039710e-37 |
GO:0051179 | localization | 4.728476e-37 |
GO:0023052 | signaling | 3.776888e-36 |
GO:0002376 | immune system process | 1.250710e-34 |
GO:0007165 | signal transduction | 1.160417e-33 |
GO:0050789 | regulation of biological process | 1.368572e-32 |
GO:0006952 | defense response | 7.571770e-32 |
GO:0007166 | cell surface receptor linked signaling pathway | 3.705282e-30 |
GO:0042221 | response to chemical stimulus | 5.929788e-30 |
GO:0050794 | regulation of cellular process | 7.269950e-30 |
GO:0046903 | secretion | 1.639298e-29 |
GO:0003008 | system process | 2.082219e-29 |
GO:0065009 | regulation of molecular function | 3.860559e-29 |
GO:0048518 | positive regulation of biological process | 9.655301e-29 |
GO:0006810 | transport | 1.779388e-28 |
GO:0051234 | establishment of localization | 2.680245e-27 |
GO:0048856 | anatomical structure development | 7.591192e-27 |
GO:0009611 | response to wounding | 1.565783e-26 |
GO:0008217 | regulation of blood pressure | 1.048165e-25 |
GO:0048519 | negative regulation of biological process | 2.476568e-25 |
GO:0006928 | cellular component movement | 3.083663e-25 |
GO:0032502 | developmental process | 3.531879e-25 |
GO:0009888 | tissue development | 1.094203e-24 |
GO:0032940 | secretion by cell | 2.539484e-24 |
GO:0048522 | positive regulation of cellular process | 9.004054e-24 |
GO:0009987 | cellular process | 1.571935e-23 |
GO:0048731 | system development | 2.073669e-23 |
GO:0048583 | regulation of response to stimulus | 1.974831e-22 |
GO:0048523 | negative regulation of cellular process | 3.050503e-22 |
GO:0010035 | response to inorganic substance | 4.595452e-22 |
GO:0002576 | platelet degranulation | 8.372315e-22 |
GO:0007275 | multicellular organismal development | 2.658391e-21 |
GO:0010038 | response to metal ion | 6.715014e-21 |
GO:0050790 | regulation of catalytic activity | 1.042370e-20 |
GO:0042060 | wound healing | 2.779257e-20 |
GO:0048584 | positive regulation of response to stimulus | 3.964303e-20 |
GO:0006955 | immune response | 9.551314e-20 |
GO:0007155 | cell adhesion | 1.618374e-19 |
GO:0009653 | anatomical structure morphogenesis | 2.324581e-19 |
GO:2000191 | regulation of fatty acid transport | 2.992797e-19 |
GO:0050865 | regulation of cell activation | 3.698566e-19 |
GO:0002694 | regulation of leukocyte activation | 3.735675e-19 |
GO:0006954 | inflammatory response | 4.649577e-19 |
GO:0042127 | regulation of cell proliferation | 5.158333e-19 |
GO:0002544 | chronic inflammatory response | 5.559852e-19 |
GO:0002696 | positive regulation of leukocyte activation | 5.628318e-19 |
GO:0001775 | cell activation | 5.680911e-19 |
GO:0050867 | positive regulation of cell activation | 8.351065e-19 |
GO:0072358 | cardiovascular system development | 1.602823e-18 |
GO:0051050 | positive regulation of transport | 3.307149e-18 |
GO:0030168 | platelet activation | 3.880010e-18 |
GO:0002682 | regulation of immune system process | 7.001575e-18 |
GO:0051641 | cellular localization | 8.059941e-18 |
GO:0045214 | sarcomere organization | 1.058783e-17 |
GO:0071840 | cellular component organization or biogenesis | 1.170018e-17 |
GO:0016043 | cellular component organization | 1.309368e-17 |
GO:0048513 | organ development | 1.397061e-17 |
GO:0030048 | actin filament-based movement | 1.408312e-17 |
GO:0002684 | positive regulation of immune system process | 1.615124e-17 |
GO:0051246 | regulation of protein metabolic process | 1.734968e-17 |
GO:0032890 | regulation of organic acid transport | 2.038848e-17 |
GO:0050878 | regulation of body fluid levels | 6.208572e-17 |
GO:0045727 | positive regulation of translation | 9.813260e-17 |
GO:0030240 | skeletal muscle thin filament assembly | 9.883257e-17 |
GO:0016192 | vesicle-mediated transport | 1.047501e-16 |
GO:0007596 | blood coagulation | 1.342312e-16 |
GO:0006887 | exocytosis | 1.783591e-16 |
GO:0008219 | cell death | 2.112580e-16 |
GO:0007599 | hemostasis | 2.170556e-16 |
GO:0070252 | actin-mediated cell contraction | 2.219172e-16 |
GO:0030049 | muscle filament sliding | 2.432982e-16 |
GO:0032879 | regulation of localization | 2.866307e-16 |
GO:0010466 | negative regulation of peptidase activity | 2.929495e-16 |
GO:0007010 | cytoskeleton organization | 3.004127e-16 |
GO:0016265 | death | 5.259708e-16 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 9.475891e-16 |
GO:0030595 | leukocyte chemotaxis | 1.240689e-15 |
GO:0009628 | response to abiotic stimulus | 1.567682e-15 |
GO:0050852 | T cell receptor signaling pathway | 1.798528e-15 |
GO:0003013 | circulatory system process | 1.896941e-15 |
GO:0009893 | positive regulation of metabolic process | 2.316554e-15 |
GO:0051049 | regulation of transport | 2.856704e-15 |
GO:0048870 | cell motility | 3.204079e-15 |
GO:0070887 | cellular response to chemical stimulus | 4.435064e-15 |
GO:0051649 | establishment of localization in cell | 6.548745e-15 |
GO:0006915 | apoptosis | 7.403970e-15 |
GO:0048644 | muscle organ morphogenesis | 8.557004e-15 |
GO:0016477 | cell migration | 1.159870e-14 |
GO:0051592 | response to calcium ion | 1.227853e-14 |
GO:0012501 | programmed cell death | 1.396029e-14 |
GO:0008015 | blood circulation | 1.631576e-14 |
GO:0050870 | positive regulation of T cell activation | 1.855837e-14 |
GO:0048747 | muscle fiber development | 2.353668e-14 |
GO:0048769 | sarcomerogenesis | 2.619489e-14 |
GO:0003012 | muscle system process | 2.675192e-14 |
GO:0032891 | negative regulation of organic acid transport | 3.796905e-14 |
GO:0006629 | lipid metabolic process | 3.924220e-14 |
GO:0006953 | acute-phase response | 5.529569e-14 |
GO:0051128 | regulation of cellular component organization | 6.262123e-14 |
GO:0048739 | cardiac muscle fiber development | 6.276528e-14 |
GO:0002437 | inflammatory response to antigenic stimulus | 6.529289e-14 |
GO:0050877 | neurological system process | 7.034468e-14 |
GO:0035556 | intracellular signal transduction | 7.705053e-14 |
GO:0010829 | negative regulation of glucose transport | 8.349203e-14 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 8.804134e-14 |
GO:0010033 | response to organic substance | 1.001077e-13 |
GO:0048468 | cell development | 1.221753e-13 |
GO:0044092 | negative regulation of molecular function | 1.243915e-13 |
GO:0008285 | negative regulation of cell proliferation | 1.421750e-13 |
GO:0032663 | regulation of interleukin-2 production | 1.485857e-13 |
GO:0031589 | cell-substrate adhesion | 1.487055e-13 |
GO:0009966 | regulation of signal transduction | 1.820986e-13 |
GO:0034605 | cellular response to heat | 1.872106e-13 |
GO:0051251 | positive regulation of lymphocyte activation | 1.897566e-13 |
GO:0060415 | muscle tissue morphogenesis | 2.171808e-13 |
GO:0040017 | positive regulation of locomotion | 2.221349e-13 |
GO:0032368 | regulation of lipid transport | 2.433063e-13 |
GO:0031622 | positive regulation of fever generation | 2.571219e-13 |
GO:0002526 | acute inflammatory response | 3.904659e-13 |
GO:0051249 | regulation of lymphocyte activation | 4.048405e-13 |
GO:0007160 | cell-matrix adhesion | 4.446147e-13 |
GO:0007267 | cell-cell signaling | 4.509839e-13 |
GO:0031325 | positive regulation of cellular metabolic process | 5.674857e-13 |
GO:0022603 | regulation of anatomical structure morphogenesis | 6.155212e-13 |
GO:0050863 | regulation of T cell activation | 6.395166e-13 |
GO:0071702 | organic substance transport | 6.423921e-13 |
GO:0032268 | regulation of cellular protein metabolic process | 9.289791e-13 |
GO:0048871 | multicellular organismal homeostasis | 1.170748e-12 |
GO:0030029 | actin filament-based process | 1.240580e-12 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 1.264891e-12 |
GO:0031652 | positive regulation of heat generation | 1.303845e-12 |
GO:0010941 | regulation of cell death | 1.405516e-12 |
GO:0050793 | regulation of developmental process | 1.757058e-12 |
GO:0055013 | cardiac muscle cell development | 1.769895e-12 |
GO:0003007 | heart morphogenesis | 1.785169e-12 |
GO:0044093 | positive regulation of molecular function | 1.878854e-12 |
GO:0010604 | positive regulation of macromolecule metabolic process | 1.952125e-12 |
GO:0009791 | post-embryonic development | 2.121420e-12 |
GO:0040007 | growth | 2.135474e-12 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 2.260866e-12 |
GO:0051346 | negative regulation of hydrolase activity | 2.304167e-12 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 2.975947e-12 |
GO:0050900 | leukocyte migration | 3.135721e-12 |
GO:0009887 | organ morphogenesis | 3.245870e-12 |
GO:0046709 | IDP catabolic process | 4.124320e-12 |
GO:0046032 | ADP catabolic process | 4.124320e-12 |
GO:0040011 | locomotion | 4.128956e-12 |
GO:0048729 | tissue morphogenesis | 4.411305e-12 |
GO:0014866 | skeletal myofibril assembly | 5.076813e-12 |
GO:0006936 | muscle contraction | 5.188917e-12 |
GO:0051336 | regulation of hydrolase activity | 5.408878e-12 |
GO:0071842 | cellular component organization at cellular level | 5.521542e-12 |
GO:0030036 | actin cytoskeleton organization | 5.788887e-12 |
GO:0032103 | positive regulation of response to external stimulus | 5.922323e-12 |
GO:0009582 | detection of abiotic stimulus | 6.211157e-12 |
GO:0043086 | negative regulation of catalytic activity | 6.443735e-12 |
GO:0051051 | negative regulation of transport | 7.713156e-12 |
GO:0050851 | antigen receptor-mediated signaling pathway | 8.098419e-12 |
GO:0040012 | regulation of locomotion | 8.847615e-12 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 9.389753e-12 |
GO:0014050 | negative regulation of glutamate secretion | 9.496416e-12 |
GO:0042981 | regulation of apoptosis | 1.018979e-11 |
GO:0030239 | myofibril assembly | 1.137033e-11 |
GO:2000147 | positive regulation of cell motility | 1.233505e-11 |
GO:0010827 | regulation of glucose transport | 1.388704e-11 |
GO:0055003 | cardiac myofibril assembly | 1.578871e-11 |
GO:0055001 | muscle cell development | 1.792539e-11 |
GO:0030335 | positive regulation of cell migration | 1.815422e-11 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 1.832027e-11 |
GO:0043067 | regulation of programmed cell death | 1.875913e-11 |
GO:0007162 | negative regulation of cell adhesion | 2.058665e-11 |
GO:0055008 | cardiac muscle tissue morphogenesis | 2.144854e-11 |
GO:0042592 | homeostatic process | 2.174586e-11 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 2.349832e-11 |
GO:0010757 | negative regulation of plasminogen activation | 2.379601e-11 |
GO:0023051 | regulation of signaling | 2.455535e-11 |
GO:0071675 | regulation of mononuclear cell migration | 2.673152e-11 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 2.747106e-11 |
GO:0071622 | regulation of granulocyte chemotaxis | 3.206933e-11 |
GO:0032101 | regulation of response to external stimulus | 3.232888e-11 |
GO:0030154 | cell differentiation | 3.513273e-11 |
GO:0007015 | actin filament organization | 3.577296e-11 |
GO:0060537 | muscle tissue development | 3.641804e-11 |
GO:0010817 | regulation of hormone levels | 4.423652e-11 |
GO:0031399 | regulation of protein modification process | 4.615709e-11 |
GO:0008207 | C21-steroid hormone metabolic process | 4.710499e-11 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 5.194789e-11 |
GO:0043503 | skeletal muscle fiber adaptation | 5.623583e-11 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 6.559294e-11 |
GO:0010876 | lipid localization | 7.154771e-11 |
GO:0043500 | muscle adaptation | 7.159446e-11 |
GO:0055002 | striated muscle cell development | 7.469980e-11 |
GO:0010759 | positive regulation of macrophage chemotaxis | 8.097327e-11 |
GO:0050778 | positive regulation of immune response | 8.100085e-11 |
GO:2000145 | regulation of cell motility | 8.572982e-11 |
GO:0042180 | cellular ketone metabolic process | 1.014123e-10 |
GO:0019222 | regulation of metabolic process | 1.015451e-10 |
GO:0051272 | positive regulation of cellular component movement | 1.062620e-10 |
GO:0030155 | regulation of cell adhesion | 1.222495e-10 |
GO:0032270 | positive regulation of cellular protein metabolic process | 1.349872e-10 |
GO:0016998 | cell wall macromolecule catabolic process | 1.367851e-10 |
GO:0051240 | positive regulation of multicellular organismal process | 1.386843e-10 |
GO:0010755 | regulation of plasminogen activation | 1.407854e-10 |
GO:0051606 | detection of stimulus | 1.466952e-10 |
GO:0023056 | positive regulation of signaling | 1.580241e-10 |
GO:0051247 | positive regulation of protein metabolic process | 1.588445e-10 |
GO:0014706 | striated muscle tissue development | 1.736902e-10 |
GO:0048869 | cellular developmental process | 1.749543e-10 |
GO:0009605 | response to external stimulus | 1.969681e-10 |
GO:0045766 | positive regulation of angiogenesis | 2.091235e-10 |
GO:0003018 | vascular process in circulatory system | 2.097651e-10 |
GO:0007507 | heart development | 2.137609e-10 |
GO:0006082 | organic acid metabolic process | 2.162755e-10 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 2.341640e-10 |
GO:0044036 | cell wall macromolecule metabolic process | 2.454885e-10 |
GO:0016049 | cell growth | 2.489593e-10 |
GO:0032880 | regulation of protein localization | 2.521423e-10 |
GO:0051239 | regulation of multicellular organismal process | 2.523482e-10 |
GO:0019752 | carboxylic acid metabolic process | 3.294481e-10 |
GO:0010758 | regulation of macrophage chemotaxis | 3.488300e-10 |
GO:0031032 | actomyosin structure organization | 3.512707e-10 |
GO:0009967 | positive regulation of signal transduction | 3.612346e-10 |
GO:0001568 | blood vessel development | 4.296314e-10 |
GO:0006448 | regulation of translational elongation | 4.464910e-10 |
GO:0050776 | regulation of immune response | 5.486567e-10 |
GO:0010647 | positive regulation of cell communication | 6.095493e-10 |
GO:0030334 | regulation of cell migration | 6.099541e-10 |
GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 6.277876e-10 |
GO:0002673 | regulation of acute inflammatory response | 6.387715e-10 |
GO:0051270 | regulation of cellular component movement | 8.336014e-10 |
GO:0044255 | cellular lipid metabolic process | 8.375168e-10 |
GO:0007076 | mitotic chromosome condensation | 1.001072e-9 |
GO:0002675 | positive regulation of acute inflammatory response | 1.027351e-9 |
GO:0070201 | regulation of establishment of protein localization | 1.027551e-9 |
GO:0070613 | regulation of protein processing | 1.043495e-9 |
GO:0010646 | regulation of cell communication | 1.201086e-9 |
GO:0032370 | positive regulation of lipid transport | 1.208688e-9 |
GO:0008360 | regulation of cell shape | 1.395521e-9 |
GO:0003006 | developmental process involved in reproduction | 1.560670e-9 |
GO:0030593 | neutrophil chemotaxis | 1.611812e-9 |
GO:0052547 | regulation of peptidase activity | 1.639918e-9 |
GO:0001944 | vasculature development | 1.642851e-9 |
GO:0001894 | tissue homeostasis | 1.718687e-9 |
GO:0032989 | cellular component morphogenesis | 1.859908e-9 |
GO:0032733 | positive regulation of interleukin-10 production | 1.885174e-9 |
GO:0044281 | small molecule metabolic process | 1.981995e-9 |
GO:0060548 | negative regulation of cell death | 2.649495e-9 |
GO:0010648 | negative regulation of cell communication | 2.711614e-9 |
GO:0023057 | negative regulation of signaling | 2.718887e-9 |
GO:0050820 | positive regulation of coagulation | 3.017484e-9 |
GO:0006811 | ion transport | 3.303836e-9 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 3.327533e-9 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 3.327533e-9 |
GO:0022607 | cellular component assembly | 3.334689e-9 |
GO:0071844 | cellular component assembly at cellular level | 3.410062e-9 |
GO:0010955 | negative regulation of protein processing | 3.426714e-9 |
GO:0009891 | positive regulation of biosynthetic process | 3.427350e-9 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 3.467679e-9 |
GO:0007517 | muscle organ development | 3.799203e-9 |
GO:0032846 | positive regulation of homeostatic process | 3.823785e-9 |
GO:0070163 | regulation of adiponectin secretion | 4.044192e-9 |
GO:0043652 | engulfment of apoptotic cell | 4.107654e-9 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 4.107654e-9 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 4.107654e-9 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 4.107654e-9 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 4.107654e-9 |
GO:0080134 | regulation of response to stress | 4.474179e-9 |
GO:0032908 | regulation of transforming growth factor beta1 production | 4.602260e-9 |
GO:0006941 | striated muscle contraction | 4.835741e-9 |
GO:0019220 | regulation of phosphate metabolic process | 4.884026e-9 |
GO:0010951 | negative regulation of endopeptidase activity | 4.911171e-9 |
GO:0002764 | immune response-regulating signaling pathway | 5.623220e-9 |
GO:0000070 | mitotic sister chromatid segregation | 6.549925e-9 |
GO:0009581 | detection of external stimulus | 6.557548e-9 |
GO:0048878 | chemical homeostasis | 7.144930e-9 |
GO:0070164 | negative regulation of adiponectin secretion | 7.572237e-9 |
GO:0060355 | positive regulation of cell adhesion molecule production | 7.572237e-9 |
GO:0035505 | positive regulation of myosin light chain kinase activity | 7.572237e-9 |
GO:0035457 | cellular response to interferon-alpha | 7.590126e-9 |
GO:0010927 | cellular component assembly involved in morphogenesis | 8.136053e-9 |
GO:0014065 | phosphatidylinositol 3-kinase cascade | 8.432379e-9 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 8.618898e-9 |
GO:0032308 | positive regulation of prostaglandin secretion | 9.358928e-9 |
GO:0007608 | sensory perception of smell | 9.928791e-9 |
GO:0007399 | nervous system development | 1.076526e-8 |
GO:0042445 | hormone metabolic process | 1.087275e-8 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1.093987e-8 |
GO:0046324 | regulation of glucose import | 1.183442e-8 |
GO:0006911 | phagocytosis, engulfment | 1.254743e-8 |
GO:0070482 | response to oxygen levels | 1.259120e-8 |
GO:0034754 | cellular hormone metabolic process | 1.352148e-8 |
GO:0001660 | fever generation | 1.398525e-8 |
GO:2000193 | positive regulation of fatty acid transport | 1.456360e-8 |
GO:0048520 | positive regulation of behavior | 1.502830e-8 |
GO:0009886 | post-embryonic morphogenesis | 1.507398e-8 |
GO:0010595 | positive regulation of endothelial cell migration | 1.519514e-8 |
GO:0033554 | cellular response to stress | 1.601813e-8 |
GO:0002757 | immune response-activating signal transduction | 1.678904e-8 |
GO:0048557 | embryonic digestive tract morphogenesis | 1.709398e-8 |
GO:0001819 | positive regulation of cytokine production | 1.711389e-8 |
GO:0032770 | positive regulation of monooxygenase activity | 1.764353e-8 |
GO:0008283 | cell proliferation | 1.817549e-8 |
GO:0030261 | chromosome condensation | 1.889210e-8 |
GO:0006916 | anti-apoptosis | 1.950786e-8 |
GO:0014829 | vascular smooth muscle contraction | 2.006628e-8 |
GO:0001525 | angiogenesis | 2.019965e-8 |
GO:0035455 | response to interferon-alpha | 2.028001e-8 |
GO:0051223 | regulation of protein transport | 2.041991e-8 |
GO:0042493 | response to drug | 2.063722e-8 |
GO:0001666 | response to hypoxia | 2.069372e-8 |
GO:0010193 | response to ozone | 2.092652e-8 |
GO:0048545 | response to steroid hormone stimulus | 2.096888e-8 |
GO:0048738 | cardiac muscle tissue development | 2.414242e-8 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 2.512327e-8 |
GO:0007600 | sensory perception | 2.562352e-8 |
GO:0007602 | phototransduction | 2.680142e-8 |
GO:0032026 | response to magnesium ion | 2.838886e-8 |
GO:0048585 | negative regulation of response to stimulus | 2.956139e-8 |
GO:0033129 | positive regulation of histone phosphorylation | 2.958797e-8 |
GO:0060326 | cell chemotaxis | 3.024019e-8 |
GO:0007566 | embryo implantation | 3.151632e-8 |
GO:0051896 | regulation of protein kinase B signaling cascade | 3.180691e-8 |
GO:0052548 | regulation of endopeptidase activity | 3.194544e-8 |
GO:0010627 | regulation of intracellular protein kinase cascade | 3.198744e-8 |
GO:0044106 | cellular amine metabolic process | 3.217621e-8 |
GO:0048485 | sympathetic nervous system development | 3.452634e-8 |
GO:0032456 | endocytic recycling | 3.665103e-8 |
GO:0042325 | regulation of phosphorylation | 3.683715e-8 |
GO:0046827 | positive regulation of protein export from nucleus | 3.697046e-8 |
GO:0000819 | sister chromatid segregation | 3.762310e-8 |
GO:0009309 | amine biosynthetic process | 3.769080e-8 |
GO:0010464 | regulation of mesenchymal cell proliferation | 3.804712e-8 |
GO:0009308 | amine metabolic process | 3.834563e-8 |
GO:0050708 | regulation of protein secretion | 4.099727e-8 |
GO:0019725 | cellular homeostasis | 4.100169e-8 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 4.118602e-8 |
GO:0050727 | regulation of inflammatory response | 4.252952e-8 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 4.311267e-8 |
GO:0031058 | positive regulation of histone modification | 4.324246e-8 |
GO:0033044 | regulation of chromosome organization | 4.405623e-8 |
GO:0009968 | negative regulation of signal transduction | 4.493630e-8 |
GO:0051895 | negative regulation of focal adhesion assembly | 4.549849e-8 |
GO:0045765 | regulation of angiogenesis | 4.561304e-8 |
GO:0008152 | metabolic process | 4.563765e-8 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 4.570469e-8 |
GO:0031099 | regeneration | 4.704127e-8 |
GO:0032892 | positive regulation of organic acid transport | 4.915998e-8 |
GO:0050921 | positive regulation of chemotaxis | 5.073365e-8 |
GO:0006996 | organelle organization | 5.243895e-8 |
GO:0008211 | glucocorticoid metabolic process | 5.263211e-8 |
GO:0031223 | auditory behavior | 5.384192e-8 |
GO:0032729 | positive regulation of interferon-gamma production | 5.429288e-8 |
GO:0002839 | positive regulation of immune response to tumor cell | 5.556498e-8 |
GO:0050818 | regulation of coagulation | 6.159574e-8 |
GO:0009266 | response to temperature stimulus | 6.372355e-8 |
GO:2000026 | regulation of multicellular organismal development | 6.549221e-8 |
GO:0055085 | transmembrane transport | 6.685259e-8 |
GO:0051222 | positive regulation of protein transport | 7.218488e-8 |
GO:0030162 | regulation of proteolysis | 7.517482e-8 |
GO:0051047 | positive regulation of secretion | 7.990493e-8 |
GO:0046626 | regulation of insulin receptor signaling pathway | 8.016428e-8 |
GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway | 8.260670e-8 |
GO:0051258 | protein polymerization | 8.701486e-8 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 9.771268e-8 |
GO:0021544 | subpallium development | 9.995087e-8 |
GO:0043462 | regulation of ATPase activity | 1.018157e-7 |
GO:0050954 | sensory perception of mechanical stimulus | 1.052424e-7 |
GO:0050729 | positive regulation of inflammatory response | 1.067044e-7 |
GO:0045338 | farnesyl diphosphate metabolic process | 1.123947e-7 |
GO:0007050 | cell cycle arrest | 1.133057e-7 |
GO:0042310 | vasoconstriction | 1.137860e-7 |
GO:0061061 | muscle structure development | 1.141813e-7 |
GO:0019221 | cytokine-mediated signaling pathway | 1.159354e-7 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 1.204921e-7 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 1.223788e-7 |
GO:0032653 | regulation of interleukin-10 production | 1.230326e-7 |
GO:0030730 | sequestering of triglyceride | 1.268434e-7 |
GO:0071310 | cellular response to organic substance | 1.332056e-7 |
GO:0042692 | muscle cell differentiation | 1.363778e-7 |
GO:0030194 | positive regulation of blood coagulation | 1.407363e-7 |
GO:0008037 | cell recognition | 1.486824e-7 |
GO:0043066 | negative regulation of apoptosis | 1.575548e-7 |
GO:0046825 | regulation of protein export from nucleus | 1.591938e-7 |
GO:0001932 | regulation of protein phosphorylation | 1.620771e-7 |
GO:0031328 | positive regulation of cellular biosynthetic process | 1.651510e-7 |
GO:0043085 | positive regulation of catalytic activity | 1.661827e-7 |
GO:0032787 | monocarboxylic acid metabolic process | 1.717401e-7 |
GO:0001501 | skeletal system development | 1.740326e-7 |
GO:0051146 | striated muscle cell differentiation | 1.793064e-7 |
GO:0048514 | blood vessel morphogenesis | 1.808548e-7 |
GO:0034284 | response to monosaccharide stimulus | 1.829996e-7 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.838866e-7 |
GO:0051130 | positive regulation of cellular component organization | 1.885141e-7 |
GO:0001655 | urogenital system development | 1.916034e-7 |
GO:0055082 | cellular chemical homeostasis | 1.930829e-7 |
GO:0033036 | macromolecule localization | 2.028160e-7 |
GO:2000353 | positive regulation of endothelial cell apoptosis | 2.083114e-7 |
GO:0055007 | cardiac muscle cell differentiation | 2.125337e-7 |
GO:0051094 | positive regulation of developmental process | 2.142355e-7 |
GO:0050996 | positive regulation of lipid catabolic process | 2.143395e-7 |
GO:0007522 | visceral muscle development | 2.228355e-7 |
GO:0009746 | response to hexose stimulus | 2.330928e-7 |
GO:0045087 | innate immune response | 2.432417e-7 |
GO:0045070 | positive regulation of viral genome replication | 2.512393e-7 |
GO:0033043 | regulation of organelle organization | 2.564946e-7 |
GO:0090084 | negative regulation of inclusion body assembly | 2.700610e-7 |
GO:0032369 | negative regulation of lipid transport | 2.791171e-7 |
GO:0045685 | regulation of glial cell differentiation | 2.977041e-7 |
GO:0034763 | negative regulation of transmembrane transport | 3.067672e-7 |
GO:0014823 | response to activity | 3.101921e-7 |
GO:0032024 | positive regulation of insulin secretion | 3.111177e-7 |
GO:0006869 | lipid transport | 3.113766e-7 |
GO:0050795 | regulation of behavior | 3.164323e-7 |
GO:0031056 | regulation of histone modification | 3.236664e-7 |
GO:0044241 | lipid digestion | 3.304778e-7 |
GO:0002687 | positive regulation of leukocyte migration | 3.360973e-7 |
GO:0045905 | positive regulation of translational termination | 3.428731e-7 |
GO:0045901 | positive regulation of translational elongation | 3.428731e-7 |
GO:0006452 | translational frameshifting | 3.428731e-7 |
GO:0010763 | positive regulation of fibroblast migration | 3.502846e-7 |
GO:0043069 | negative regulation of programmed cell death | 3.504986e-7 |
GO:0043032 | positive regulation of macrophage activation | 3.517025e-7 |
GO:0048566 | embryonic digestive tract development | 3.538478e-7 |
GO:0050880 | regulation of blood vessel size | 3.625820e-7 |
GO:0035150 | regulation of tube size | 3.710463e-7 |
GO:0009749 | response to glucose stimulus | 3.833478e-7 |
GO:2000171 | negative regulation of dendrite development | 4.506361e-7 |
GO:0009607 | response to biotic stimulus | 4.567900e-7 |
GO:0050920 | regulation of chemotaxis | 4.662865e-7 |
GO:0007417 | central nervous system development | 4.810834e-7 |
GO:0051241 | negative regulation of multicellular organismal process | 4.886910e-7 |
GO:0019538 | protein metabolic process | 4.914700e-7 |
GO:0046942 | carboxylic acid transport | 4.960959e-7 |
GO:0043129 | surfactant homeostasis | 5.196462e-7 |
GO:0046887 | positive regulation of hormone secretion | 5.262843e-7 |
GO:0001546 | preantral ovarian follicle growth | 5.263824e-7 |
GO:0002253 | activation of immune response | 5.326299e-7 |
GO:0044085 | cellular component biogenesis | 5.344406e-7 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.463624e-7 |
GO:0007613 | memory | 5.554382e-7 |
GO:0051918 | negative regulation of fibrinolysis | 5.634471e-7 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 5.654387e-7 |
GO:0022407 | regulation of cell-cell adhesion | 5.758958e-7 |
GO:0000165 | MAPKKK cascade | 6.197106e-7 |
GO:0015849 | organic acid transport | 6.261756e-7 |
GO:0010638 | positive regulation of organelle organization | 6.389834e-7 |
GO:0010226 | response to lithium ion | 6.423259e-7 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 6.492561e-7 |
GO:0010812 | negative regulation of cell-substrate adhesion | 6.603276e-7 |
GO:0002711 | positive regulation of T cell mediated immunity | 6.943877e-7 |
GO:0002699 | positive regulation of immune effector process | 7.020901e-7 |
GO:0008610 | lipid biosynthetic process | 7.038832e-7 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | 7.593314e-7 |
GO:0051235 | maintenance of location | 7.732151e-7 |
GO:0070294 | renal sodium ion absorption | 8.482636e-7 |
GO:0034014 | response to triglyceride | 8.596200e-7 |
GO:0051707 | response to other organism | 9.404342e-7 |
GO:0006508 | proteolysis | 9.480879e-7 |
GO:0070383 | DNA cytosine deamination | 9.825030e-7 |
GO:0043163 | cell envelope organization | 9.825030e-7 |
GO:0051648 | vesicle localization | 9.843734e-7 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 1.003564e-6 |
GO:0060341 | regulation of cellular localization | 1.021734e-6 |
GO:0018149 | peptide cross-linking | 1.040732e-6 |
GO:0002821 | positive regulation of adaptive immune response | 1.041099e-6 |
GO:0030003 | cellular cation homeostasis | 1.042962e-6 |
GO:0090277 | positive regulation of peptide hormone secretion | 1.061073e-6 |
GO:0060675 | ureteric bud morphogenesis | 1.068645e-6 |
GO:0051917 | regulation of fibrinolysis | 1.087150e-6 |
GO:0031529 | ruffle organization | 1.110732e-6 |
GO:0009617 | response to bacterium | 1.121533e-6 |
GO:0031214 | biomineral tissue development | 1.130186e-6 |
GO:0046394 | carboxylic acid biosynthetic process | 1.188431e-6 |
GO:0046325 | negative regulation of glucose import | 1.196126e-6 |
GO:0043507 | positive regulation of JUN kinase activity | 1.217478e-6 |
GO:0044238 | primary metabolic process | 1.235944e-6 |
GO:0051248 | negative regulation of protein metabolic process | 1.236045e-6 |
GO:0009296 | flagellum assembly | 1.238812e-6 |
GO:0032269 | negative regulation of cellular protein metabolic process | 1.250201e-6 |
GO:0007606 | sensory perception of chemical stimulus | 1.303136e-6 |
GO:0051893 | regulation of focal adhesion assembly | 1.307175e-6 |
GO:0045995 | regulation of embryonic development | 1.327003e-6 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 1.343721e-6 |
GO:0055080 | cation homeostasis | 1.345162e-6 |
GO:0030193 | regulation of blood coagulation | 1.353699e-6 |
GO:0008202 | steroid metabolic process | 1.390489e-6 |
GO:0002793 | positive regulation of peptide secretion | 1.411656e-6 |
GO:0007638 | mechanosensory behavior | 1.435876e-6 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.442304e-6 |
GO:0032649 | regulation of interferon-gamma production | 1.494186e-6 |
GO:0021756 | striatum development | 1.514785e-6 |
GO:0010243 | response to organic nitrogen | 1.576603e-6 |
GO:0007420 | brain development | 1.591685e-6 |
GO:0060562 | epithelial tube morphogenesis | 1.633634e-6 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050896 | response to stimulus | 9.206259e-27 |
GO:0051716 | cellular response to stimulus | 7.583972e-19 |
GO:0030300 | regulation of intestinal cholesterol absorption | 2.161604e-18 |
GO:0033344 | cholesterol efflux | 7.313653e-17 |
GO:0007165 | signal transduction | 5.557906e-16 |
GO:0033700 | phospholipid efflux | 8.909416e-16 |
GO:0032374 | regulation of cholesterol transport | 1.459261e-15 |
GO:0016125 | sterol metabolic process | 6.419602e-15 |
GO:0006581 | acetylcholine catabolic process | 2.872194e-14 |
GO:0008203 | cholesterol metabolic process | 5.328218e-14 |
GO:0034369 | plasma lipoprotein particle remodeling | 9.853623e-14 |
GO:0071827 | plasma lipoprotein particle organization | 2.647114e-13 |
GO:0032368 | regulation of lipid transport | 2.797874e-13 |
GO:0044281 | small molecule metabolic process | 3.541450e-13 |
GO:0042157 | lipoprotein metabolic process | 5.543136e-13 |
GO:0015914 | phospholipid transport | 6.556699e-13 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 6.830533e-13 |
GO:0044241 | lipid digestion | 1.160442e-12 |
GO:0033058 | directional locomotion | 2.583917e-12 |
GO:0044058 | regulation of digestive system process | 3.818105e-12 |
GO:0023052 | signaling | 3.934495e-12 |
GO:0032375 | negative regulation of cholesterol transport | 3.976022e-12 |
GO:0042304 | regulation of fatty acid biosynthetic process | 4.165234e-12 |
GO:0007154 | cell communication | 4.460345e-12 |
GO:0042743 | hydrogen peroxide metabolic process | 4.636570e-12 |
GO:0043056 | forward locomotion | 5.297533e-12 |
GO:0006869 | lipid transport | 7.433890e-12 |
GO:0008291 | acetylcholine metabolic process | 1.386520e-11 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 1.457820e-11 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 2.079366e-11 |
GO:0010876 | lipid localization | 3.270716e-11 |
GO:0006982 | response to lipid hydroperoxide | 3.279394e-11 |
GO:0009308 | amine metabolic process | 4.781917e-11 |
GO:0006629 | lipid metabolic process | 4.910964e-11 |
GO:0032369 | negative regulation of lipid transport | 5.520151e-11 |
GO:0010873 | positive regulation of cholesterol esterification | 6.645109e-11 |
GO:0002694 | regulation of leukocyte activation | 7.279580e-11 |
GO:0007166 | cell surface receptor linked signaling pathway | 7.436479e-11 |
GO:0030301 | cholesterol transport | 9.440087e-11 |
GO:0006278 | RNA-dependent DNA replication | 9.632619e-11 |
GO:0006950 | response to stress | 9.812779e-11 |
GO:0050746 | regulation of lipoprotein metabolic process | 1.306277e-10 |
GO:0071702 | organic substance transport | 1.386588e-10 |
GO:0010872 | regulation of cholesterol esterification | 2.078378e-10 |
GO:0006952 | defense response | 2.106956e-10 |
GO:0042439 | ethanolamine-containing compound metabolic process | 2.111330e-10 |
GO:2000351 | regulation of endothelial cell apoptosis | 2.667538e-10 |
GO:0043691 | reverse cholesterol transport | 2.676695e-10 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 2.800281e-10 |
GO:0006955 | immune response | 2.838849e-10 |
GO:0007155 | cell adhesion | 4.463805e-10 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 6.862361e-10 |
GO:0022610 | biological adhesion | 7.496000e-10 |
GO:0050865 | regulation of cell activation | 8.291235e-10 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.030866e-9 |
GO:0034442 | regulation of lipoprotein oxidation | 1.042049e-9 |
GO:0002521 | leukocyte differentiation | 1.133588e-9 |
GO:0090207 | regulation of triglyceride metabolic process | 1.215642e-9 |
GO:0044255 | cellular lipid metabolic process | 1.356886e-9 |
GO:0045940 | positive regulation of steroid metabolic process | 1.561760e-9 |
GO:0042135 | neurotransmitter catabolic process | 1.760974e-9 |
GO:0008202 | steroid metabolic process | 1.904831e-9 |
GO:0010896 | regulation of triglyceride catabolic process | 1.959478e-9 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 2.403601e-9 |
GO:0007586 | digestion | 2.860672e-9 |
GO:0042744 | hydrogen peroxide catabolic process | 3.678457e-9 |
GO:0009628 | response to abiotic stimulus | 4.002755e-9 |
GO:0002227 | innate immune response in mucosa | 4.898509e-9 |
GO:0065005 | protein-lipid complex assembly | 6.579007e-9 |
GO:0002700 | regulation of production of molecular mediator of immune response | 7.793007e-9 |
GO:0033003 | regulation of mast cell activation | 1.269269e-8 |
GO:0006066 | alcohol metabolic process | 1.564530e-8 |
GO:0042402 | cellular biogenic amine catabolic process | 1.596278e-8 |
GO:0032800 | receptor biosynthetic process | 1.880452e-8 |
GO:0030183 | B cell differentiation | 1.916235e-8 |
GO:0043503 | skeletal muscle fiber adaptation | 2.031243e-8 |
GO:0030204 | chondroitin sulfate metabolic process | 2.304945e-8 |
GO:0051250 | negative regulation of lymphocyte activation | 2.325734e-8 |
GO:0010565 | regulation of cellular ketone metabolic process | 2.534344e-8 |
GO:0030299 | intestinal cholesterol absorption | 2.542514e-8 |
GO:0002695 | negative regulation of leukocyte activation | 3.645360e-8 |
GO:0046890 | regulation of lipid biosynthetic process | 4.212940e-8 |
GO:0050957 | equilibrioception | 4.811662e-8 |
GO:0002376 | immune system process | 5.020794e-8 |
GO:0030203 | glycosaminoglycan metabolic process | 5.682738e-8 |
GO:0046470 | phosphatidylcholine metabolic process | 6.447211e-8 |
GO:0048565 | digestive tract development | 6.628791e-8 |
GO:0006082 | organic acid metabolic process | 7.371967e-8 |
GO:0016042 | lipid catabolic process | 8.062413e-8 |
GO:0055003 | cardiac myofibril assembly | 8.288690e-8 |
GO:0090130 | tissue migration | 8.784081e-8 |
GO:0070301 | cellular response to hydrogen peroxide | 9.074959e-8 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 9.541543e-8 |
GO:0006664 | glycolipid metabolic process | 1.103427e-7 |
GO:0009611 | response to wounding | 1.133302e-7 |
GO:0002682 | regulation of immune system process | 1.146664e-7 |
GO:0006108 | malate metabolic process | 1.175440e-7 |
GO:0006022 | aminoglycan metabolic process | 1.330253e-7 |
GO:0035023 | regulation of Rho protein signal transduction | 1.369209e-7 |
GO:0050994 | regulation of lipid catabolic process | 1.424810e-7 |
GO:0050996 | positive regulation of lipid catabolic process | 1.505996e-7 |
GO:0050866 | negative regulation of cell activation | 1.588218e-7 |
GO:0042180 | cellular ketone metabolic process | 1.744474e-7 |
GO:0030098 | lymphocyte differentiation | 1.774884e-7 |
GO:0035556 | intracellular signal transduction | 1.804603e-7 |
GO:0019217 | regulation of fatty acid metabolic process | 2.001186e-7 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 2.017536e-7 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.316228e-7 |
GO:0044242 | cellular lipid catabolic process | 2.385498e-7 |
GO:0002076 | osteoblast development | 2.527162e-7 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 2.577592e-7 |
GO:0019752 | carboxylic acid metabolic process | 2.647862e-7 |
GO:0051048 | negative regulation of secretion | 2.752349e-7 |
GO:0010898 | positive regulation of triglyceride catabolic process | 2.797444e-7 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 2.904175e-7 |
GO:0046889 | positive regulation of lipid biosynthetic process | 2.978740e-7 |
GO:0051249 | regulation of lymphocyte activation | 3.155611e-7 |
GO:0042113 | B cell activation | 3.573506e-7 |
GO:0010984 | regulation of lipoprotein particle clearance | 3.771215e-7 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 3.985387e-7 |
GO:0055090 | acylglycerol homeostasis | 4.293013e-7 |
GO:0001775 | cell activation | 4.310571e-7 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 4.381583e-7 |
GO:0033993 | response to lipid | 4.393522e-7 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 4.420296e-7 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 4.420296e-7 |
GO:0032501 | multicellular organismal process | 4.470857e-7 |
GO:0050776 | regulation of immune response | 4.609081e-7 |
GO:0002697 | regulation of immune effector process | 4.677326e-7 |
GO:0018924 | mandelate metabolic process | 4.932324e-7 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.979059e-7 |
GO:0090208 | positive regulation of triglyceride metabolic process | 5.158733e-7 |
GO:0046649 | lymphocyte activation | 5.507577e-7 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 5.696581e-7 |
GO:0045834 | positive regulation of lipid metabolic process | 5.732280e-7 |
GO:0010033 | response to organic substance | 6.318395e-7 |
GO:0008283 | cell proliferation | 6.347169e-7 |
GO:0009056 | catabolic process | 6.366452e-7 |
GO:0042246 | tissue regeneration | 7.726599e-7 |
GO:0045321 | leukocyte activation | 7.730015e-7 |
GO:0044240 | multicellular organismal lipid catabolic process | 9.669314e-7 |
GO:0014823 | response to activity | 1.110662e-6 |
GO:0009117 | nucleotide metabolic process | 1.110693e-6 |
GO:0002819 | regulation of adaptive immune response | 1.157661e-6 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 1.162840e-6 |
GO:0046503 | glycerolipid catabolic process | 1.196154e-6 |
GO:0060317 | cardiac epithelial to mesenchymal transition | 1.212112e-6 |
GO:0050869 | negative regulation of B cell activation | 1.396606e-6 |
GO:0020027 | hemoglobin metabolic process | 1.433438e-6 |
GO:0034699 | response to luteinizing hormone stimulus | 1.465867e-6 |
GO:0070328 | triglyceride homeostasis | 1.494376e-6 |
GO:0046642 | negative regulation of alpha-beta T cell proliferation | 1.607962e-6 |
GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 1.725437e-6 |
GO:0006164 | purine nucleotide biosynthetic process | 1.809656e-6 |
GO:0032276 | regulation of gonadotropin secretion | 1.867401e-6 |
GO:0040007 | growth | 2.022960e-6 |
GO:0045471 | response to ethanol | 2.122727e-6 |
GO:0019376 | galactolipid catabolic process | 2.190491e-6 |
GO:0010035 | response to inorganic substance | 2.310087e-6 |
GO:0043933 | macromolecular complex subunit organization | 2.455071e-6 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 2.522568e-6 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 2.648359e-6 |
GO:0019695 | choline metabolic process | 2.746811e-6 |
GO:0006641 | triglyceride metabolic process | 2.821469e-6 |
GO:0044243 | multicellular organismal catabolic process | 2.992549e-6 |
GO:0045923 | positive regulation of fatty acid metabolic process | 3.009890e-6 |
GO:0050864 | regulation of B cell activation | 3.120964e-6 |
GO:0006576 | cellular biogenic amine metabolic process | 3.192943e-6 |
GO:0008054 | cyclin catabolic process | 3.268910e-6 |
GO:0030154 | cell differentiation | 3.372127e-6 |
GO:0042632 | cholesterol homeostasis | 3.564099e-6 |
GO:0014866 | skeletal myofibril assembly | 3.754007e-6 |
GO:0030240 | skeletal muscle thin filament assembly | 3.886003e-6 |
GO:0006687 | glycosphingolipid metabolic process | 3.968471e-6 |
GO:0072593 | reactive oxygen species metabolic process | 3.997556e-6 |
GO:0000072 | M phase specific microtubule process | 4.056135e-6 |
GO:0019693 | ribose phosphate metabolic process | 4.297531e-6 |
GO:0019433 | triglyceride catabolic process | 4.377142e-6 |
GO:0018904 | organic ether metabolic process | 4.766111e-6 |
GO:0048566 | embryonic digestive tract development | 4.940505e-6 |
GO:0030097 | hemopoiesis | 4.989896e-6 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 5.024901e-6 |
GO:0051234 | establishment of localization | 5.056655e-6 |
GO:0070848 | response to growth factor stimulus | 5.617311e-6 |
GO:0046464 | acylglycerol catabolic process | 5.648768e-6 |
GO:0046483 | heterocycle metabolic process | 5.791858e-6 |
GO:0046328 | regulation of JNK cascade | 5.942536e-6 |
GO:0070508 | cholesterol import | 5.951869e-6 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 6.323230e-6 |
GO:0002637 | regulation of immunoglobulin production | 6.333053e-6 |
GO:0031032 | actomyosin structure organization | 6.479886e-6 |
GO:0006810 | transport | 6.494498e-6 |
GO:0050863 | regulation of T cell activation | 6.519519e-6 |
GO:0035121 | tail morphogenesis | 6.760479e-6 |
GO:0000212 | meiotic spindle organization | 6.967233e-6 |
GO:0006639 | acylglycerol metabolic process | 7.072599e-6 |
GO:0019218 | regulation of steroid metabolic process | 7.515164e-6 |
GO:0072521 | purine-containing compound metabolic process | 7.636381e-6 |
GO:0006014 | D-ribose metabolic process | 8.004494e-6 |
GO:0009653 | anatomical structure morphogenesis | 8.038350e-6 |
GO:0035235 | ionotropic glutamate receptor signaling pathway | 8.336350e-6 |
GO:0019370 | leukotriene biosynthetic process | 8.338590e-6 |
GO:0006662 | glycerol ether metabolic process | 8.673025e-6 |
GO:0034605 | cellular response to heat | 8.762168e-6 |
GO:0072522 | purine-containing compound biosynthetic process | 8.870270e-6 |
GO:0030888 | regulation of B cell proliferation | 8.889738e-6 |
GO:0044106 | cellular amine metabolic process | 9.151045e-6 |
GO:0048856 | anatomical structure development | 9.250183e-6 |
GO:0045682 | regulation of epidermis development | 9.415027e-6 |
GO:0010954 | positive regulation of protein processing | 9.421093e-6 |
GO:0048869 | cellular developmental process | 9.458456e-6 |
GO:0050906 | detection of stimulus involved in sensory perception | 9.665210e-6 |
GO:0032185 | septin cytoskeleton organization | 1.013901e-5 |
GO:0044248 | cellular catabolic process | 1.093170e-5 |
GO:0045989 | positive regulation of striated muscle contraction | 1.112274e-5 |
GO:0046034 | ATP metabolic process | 1.128990e-5 |
GO:0042542 | response to hydrogen peroxide | 1.132429e-5 |
GO:0045599 | negative regulation of fat cell differentiation | 1.230161e-5 |
GO:0002703 | regulation of leukocyte mediated immunity | 1.256823e-5 |
GO:0015816 | glycine transport | 1.286237e-5 |
GO:0006691 | leukotriene metabolic process | 1.314803e-5 |
GO:0006643 | membrane lipid metabolic process | 1.319361e-5 |
GO:0006801 | superoxide metabolic process | 1.332507e-5 |
GO:0051051 | negative regulation of transport | 1.350346e-5 |
GO:0055013 | cardiac muscle cell development | 1.395811e-5 |
GO:0051023 | regulation of immunoglobulin secretion | 1.420997e-5 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1.488412e-5 |
GO:0043506 | regulation of JUN kinase activity | 1.524588e-5 |
GO:0006163 | purine nucleotide metabolic process | 1.526367e-5 |
GO:0007021 | tubulin complex assembly | 1.563473e-5 |
GO:0019430 | removal of superoxide radicals | 1.588132e-5 |
GO:0006468 | protein phosphorylation | 1.652595e-5 |
GO:0006029 | proteoglycan metabolic process | 1.692648e-5 |
GO:0035588 | G-protein coupled purinergic receptor signaling pathway | 1.713630e-5 |
GO:0007159 | leukocyte cell-cell adhesion | 1.800616e-5 |
GO:0035330 | regulation of hippo signaling cascade | 1.824184e-5 |
GO:0035587 | purinergic receptor signaling pathway | 1.843234e-5 |
GO:0006638 | neutral lipid metabolic process | 1.898353e-5 |
GO:0008610 | lipid biosynthetic process | 1.906696e-5 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 2.057202e-5 |
GO:0006897 | endocytosis | 2.104309e-5 |
GO:0046466 | membrane lipid catabolic process | 2.131140e-5 |
GO:0008078 | mesodermal cell migration | 2.193411e-5 |
GO:0055006 | cardiac cell development | 2.202212e-5 |
GO:0065007 | biological regulation | 2.292647e-5 |
GO:0044283 | small molecule biosynthetic process | 2.315742e-5 |
GO:0060457 | negative regulation of digestive system process | 2.316457e-5 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 2.316457e-5 |
GO:0010226 | response to lithium ion | 2.327744e-5 |
GO:0034382 | chylomicron remnant clearance | 2.378905e-5 |
GO:0048583 | regulation of response to stimulus | 2.410069e-5 |
GO:0007509 | mesoderm migration involved in gastrulation | 2.453236e-5 |
GO:2000353 | positive regulation of endothelial cell apoptosis | 2.459314e-5 |
GO:0030321 | transepithelial chloride transport | 2.459314e-5 |
GO:0001969 | regulation of activation of membrane attack complex | 2.558079e-5 |
GO:0042221 | response to chemical stimulus | 2.659819e-5 |
GO:0060191 | regulation of lipase activity | 2.836832e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 2.994413e-5 |
GO:0009165 | nucleotide biosynthetic process | 2.997012e-5 |
GO:0048534 | hemopoietic or lymphoid organ development | 3.013446e-5 |
GO:0055123 | digestive system development | 3.019471e-5 |
GO:0002252 | immune effector process | 3.030730e-5 |
GO:0009310 | amine catabolic process | 3.067223e-5 |
GO:0043507 | positive regulation of JUN kinase activity | 3.147222e-5 |
GO:0007512 | adult heart development | 3.209908e-5 |
GO:0090234 | regulation of kinetochore assembly | 3.271176e-5 |
GO:0090169 | regulation of spindle assembly | 3.271176e-5 |
GO:0030036 | actin cytoskeleton organization | 3.289188e-5 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.304378e-5 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 3.392931e-5 |
GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 3.392931e-5 |
GO:0007442 | hindgut morphogenesis | 3.450639e-5 |
GO:0070349 | positive regulation of brown fat cell proliferation | 3.722637e-5 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 3.722637e-5 |
GO:0010038 | response to metal ion | 3.881179e-5 |
GO:0048676 | axon extension involved in development | 3.970900e-5 |
GO:0051046 | regulation of secretion | 4.033024e-5 |
GO:0055088 | lipid homeostasis | 4.071437e-5 |
GO:0019216 | regulation of lipid metabolic process | 4.101779e-5 |
GO:0043252 | sodium-independent organic anion transport | 4.135056e-5 |
GO:0007271 | synaptic transmission, cholinergic | 4.246168e-5 |
GO:0042110 | T cell activation | 4.304781e-5 |
GO:0007010 | cytoskeleton organization | 4.305559e-5 |
GO:0032321 | positive regulation of Rho GTPase activity | 4.416348e-5 |
GO:0060461 | right lung morphogenesis | 4.484389e-5 |
GO:0060446 | branching involved in open tracheal system development | 4.484389e-5 |
GO:0090131 | mesenchyme migration | 4.484389e-5 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 4.484389e-5 |
GO:0014822 | detection of wounding | 4.484389e-5 |
GO:0048371 | lateral mesodermal cell differentiation | 4.484389e-5 |
GO:0002251 | organ or tissue specific immune response | 4.607403e-5 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 4.648053e-5 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 4.795587e-5 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 4.872134e-5 |
GO:0060754 | positive regulation of mast cell chemotaxis | 4.872134e-5 |
GO:0060696 | regulation of phospholipid catabolic process | 4.872134e-5 |
GO:0071363 | cellular response to growth factor stimulus | 4.893762e-5 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.054103e-5 |
GO:0006814 | sodium ion transport | 5.092248e-5 |
GO:0048709 | oligodendrocyte differentiation | 5.092412e-5 |
GO:0031667 | response to nutrient levels | 5.094238e-5 |
GO:0072668 | tubulin complex biogenesis | 5.173197e-5 |
GO:0007257 | activation of JUN kinase activity | 5.284231e-5 |
GO:0055080 | cation homeostasis | 5.490992e-5 |
GO:0060193 | positive regulation of lipase activity | 5.574129e-5 |
GO:0061053 | somite development | 5.668103e-5 |
GO:0040018 | positive regulation of multicellular organism growth | 5.755486e-5 |
GO:0006467 | protein thiol-disulfide exchange | 5.767519e-5 |
GO:0048286 | lung alveolus development | 5.820323e-5 |
GO:0034381 | plasma lipoprotein particle clearance | 5.836124e-5 |
GO:0048731 | system development | 5.855433e-5 |
GO:0002718 | regulation of cytokine production involved in immune response | 5.933567e-5 |
GO:0050709 | negative regulation of protein secretion | 6.041145e-5 |
GO:0061029 | eyelid development in camera-type eye | 6.102473e-5 |
GO:0042756 | drinking behavior | 6.137590e-5 |
GO:0002683 | negative regulation of immune system process | 6.341386e-5 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 6.567014e-5 |
GO:0035814 | negative regulation of renal sodium excretion | 6.699551e-5 |
GO:0002821 | positive regulation of adaptive immune response | 6.987018e-5 |
GO:0016126 | sterol biosynthetic process | 7.093455e-5 |
GO:0001570 | vasculogenesis | 7.106290e-5 |
GO:0009991 | response to extracellular stimulus | 7.115272e-5 |
GO:0031330 | negative regulation of cellular catabolic process | 7.274759e-5 |
GO:0006695 | cholesterol biosynthetic process | 7.583915e-5 |
GO:0009895 | negative regulation of catabolic process | 7.588623e-5 |
GO:0018149 | peptide cross-linking | 7.691296e-5 |
GO:0050892 | intestinal absorption | 7.715769e-5 |
GO:0010994 | free ubiquitin chain polymerization | 7.956221e-5 |
GO:0035112 | genitalia morphogenesis | 8.120874e-5 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 8.288750e-5 |
GO:0045581 | negative regulation of T cell differentiation | 8.379134e-5 |
GO:0030003 | cellular cation homeostasis | 8.455912e-5 |
GO:0000303 | response to superoxide | 8.490835e-5 |
GO:0006665 | sphingolipid metabolic process | 8.775632e-5 |
GO:0022607 | cellular component assembly | 8.841709e-5 |
GO:0022600 | digestive system process | 8.862066e-5 |
GO:0009123 | nucleoside monophosphate metabolic process | 8.867272e-5 |
GO:0031099 | regeneration | 9.193774e-5 |
GO:0071474 | cellular hyperosmotic response | 9.311597e-5 |
GO:0010927 | cellular component assembly involved in morphogenesis | 9.410426e-5 |
GO:0034614 | cellular response to reactive oxygen species | 9.575473e-5 |
GO:0021776 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 9.820935e-5 |
GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 9.820935e-5 |
GO:0070228 | regulation of lymphocyte apoptosis | 9.869265e-5 |
GO:0046880 | regulation of follicle-stimulating hormone secretion | 9.896149e-5 |
GO:0014013 | regulation of gliogenesis | 9.953724e-5 |
GO:0002520 | immune system development | 1.003222e-4 |
GO:0009260 | ribonucleotide biosynthetic process | 1.010280e-4 |
GO:0007215 | glutamate signaling pathway | 1.015692e-4 |
GO:0071840 | cellular component organization or biogenesis | 1.020805e-4 |
GO:0007020 | microtubule nucleation | 1.023140e-4 |
GO:0002066 | columnar/cuboidal epithelial cell development | 1.023140e-4 |
GO:0060576 | intestinal epithelial cell development | 1.026073e-4 |
GO:0043501 | skeletal muscle adaptation | 1.026566e-4 |
GO:0032502 | developmental process | 1.036370e-4 |
GO:0050708 | regulation of protein secretion | 1.038673e-4 |
GO:0002385 | mucosal immune response | 1.040016e-4 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 1.056093e-4 |
GO:0051241 | negative regulation of multicellular organismal process | 1.061133e-4 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 1.066935e-4 |
GO:0000305 | response to oxygen radical | 1.077369e-4 |
GO:0055114 | oxidation-reduction process | 1.096940e-4 |
GO:0007584 | response to nutrient | 1.097821e-4 |
GO:0045604 | regulation of epidermal cell differentiation | 1.100162e-4 |
GO:0018130 | heterocycle biosynthetic process | 1.137035e-4 |
GO:0032319 | regulation of Rho GTPase activity | 1.142818e-4 |
GO:0042158 | lipoprotein biosynthetic process | 1.144461e-4 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 1.146202e-4 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.170956e-4 |
GO:0009259 | ribonucleotide metabolic process | 1.177489e-4 |
GO:0060575 | intestinal epithelial cell differentiation | 1.177622e-4 |
GO:0065003 | macromolecular complex assembly | 1.196810e-4 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 1.201308e-4 |
GO:0002335 | mature B cell differentiation | 1.219434e-4 |
GO:0048878 | chemical homeostasis | 1.234083e-4 |
GO:0001820 | serotonin secretion | 1.274707e-4 |
GO:0006650 | glycerophospholipid metabolic process | 1.286531e-4 |
GO:0048671 | negative regulation of collateral sprouting | 1.288253e-4 |
GO:0009612 | response to mechanical stimulus | 1.414743e-4 |
GO:0006725 | cellular aromatic compound metabolic process | 1.430695e-4 |
GO:0048589 | developmental growth | 1.433122e-4 |
GO:0045616 | regulation of keratinocyte differentiation | 1.446591e-4 |
GO:0030217 | T cell differentiation | 1.450150e-4 |
GO:0001970 | positive regulation of activation of membrane attack complex | 1.520432e-4 |
GO:0002883 | regulation of hypersensitivity | 1.537729e-4 |
GO:0002885 | positive regulation of hypersensitivity | 1.541239e-4 |
GO:0009150 | purine ribonucleotide metabolic process | 1.541262e-4 |
GO:0046486 | glycerolipid metabolic process | 1.566032e-4 |
GO:0000105 | histidine biosynthetic process | 1.571090e-4 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.573567e-4 |
GO:0032277 | negative regulation of gonadotropin secretion | 1.576015e-4 |
GO:0046636 | negative regulation of alpha-beta T cell activation | 1.576391e-4 |
GO:0030316 | osteoclast differentiation | 1.598327e-4 |
GO:0002684 | positive regulation of immune system process | 1.617773e-4 |
GO:0016043 | cellular component organization | 1.671658e-4 |
GO:0032944 | regulation of mononuclear cell proliferation | 1.679886e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.680360e-4 |
GO:0030382 | sperm mitochondrion organization | 1.701329e-4 |
GO:0043305 | negative regulation of mast cell degranulation | 1.701329e-4 |
GO:0009992 | cellular water homeostasis | 1.701329e-4 |
GO:0035092 | sperm chromatin condensation | 1.716415e-4 |
GO:0002903 | negative regulation of B cell apoptosis | 1.728593e-4 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 1.731400e-4 |
GO:0045580 | regulation of T cell differentiation | 1.734789e-4 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 1.742129e-4 |
GO:0050670 | regulation of lymphocyte proliferation | 1.749477e-4 |
GO:0003008 | system process | 1.767390e-4 |
GO:0032890 | regulation of organic acid transport | 1.815614e-4 |
GO:0045213 | neurotransmitter receptor metabolic process | 1.820298e-4 |
GO:0043304 | regulation of mast cell degranulation | 1.822717e-4 |
GO:0010507 | negative regulation of autophagy | 1.822717e-4 |
GO:0002699 | positive regulation of immune effector process | 1.877808e-4 |
GO:0002360 | T cell lineage commitment | 1.892672e-4 |
GO:0070663 | regulation of leukocyte proliferation | 1.917694e-4 |
GO:0070542 | response to fatty acid | 1.947086e-4 |
GO:0006970 | response to osmotic stress | 1.988175e-4 |
GO:0050868 | negative regulation of T cell activation | 2.008946e-4 |
GO:0014003 | oligodendrocyte development | 2.122838e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 2.134286e-4 |
GO:0007264 | small GTPase mediated signal transduction | 2.156372e-4 |
GO:0009152 | purine ribonucleotide biosynthetic process | 2.175578e-4 |
GO:0014074 | response to purine-containing compound | 2.191616e-4 |
GO:0006915 | apoptosis | 2.242394e-4 |
GO:0001878 | response to yeast | 2.271072e-4 |
GO:0045598 | regulation of fat cell differentiation | 2.273383e-4 |
GO:2000348 | regulation of CD40 signaling pathway | 2.285275e-4 |
GO:0030029 | actin filament-based process | 2.389409e-4 |
GO:0030890 | positive regulation of B cell proliferation | 2.408342e-4 |
GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process | 2.457718e-4 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 2.457718e-4 |
GO:0065009 | regulation of molecular function | 2.530820e-4 |
GO:0060513 | prostatic bud formation | 2.546154e-4 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 2.546154e-4 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 2.557635e-4 |
GO:0051179 | localization | 2.560610e-4 |
GO:0030168 | platelet activation | 2.570858e-4 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 2.591700e-4 |
GO:0043408 | regulation of MAPKKK cascade | 2.611136e-4 |
GO:0046514 | ceramide catabolic process | 2.638138e-4 |
GO:0006875 | cellular metal ion homeostasis | 2.654997e-4 |
GO:0030239 | myofibril assembly | 2.670791e-4 |
GO:0051707 | response to other organism | 2.680016e-4 |
GO:0006144 | purine base metabolic process | 2.699005e-4 |
GO:0050789 | regulation of biological process | 2.709077e-4 |
GO:0033194 | response to hydroperoxide | 2.726771e-4 |
GO:0048513 | organ development | 2.740235e-4 |
GO:0071375 | cellular response to peptide hormone stimulus | 2.794032e-4 |
GO:0002675 | positive regulation of acute inflammatory response | 2.834004e-4 |
GO:0072358 | cardiovascular system development | 2.862020e-4 |
GO:0070887 | cellular response to chemical stimulus | 2.867793e-4 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 2.955309e-4 |
GO:0070367 | negative regulation of hepatocyte differentiation | 2.955309e-4 |
GO:0051272 | positive regulation of cellular component movement | 3.004985e-4 |
GO:0042178 | xenobiotic catabolic process | 3.016279e-4 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 3.026540e-4 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 3.062216e-4 |
GO:0051258 | protein polymerization | 3.064398e-4 |
GO:2000147 | positive regulation of cell motility | 3.091446e-4 |
GO:0019374 | galactolipid metabolic process | 3.115173e-4 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 3.143112e-4 |
GO:0032879 | regulation of localization | 3.190150e-4 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 3.211275e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 3.215163e-4 |
GO:0002922 | positive regulation of humoral immune response | 3.234685e-4 |
GO:0016310 | phosphorylation | 3.249399e-4 |
GO:0045620 | negative regulation of lymphocyte differentiation | 3.290065e-4 |
GO:2000347 | positive regulation of hepatocyte proliferation | 3.308333e-4 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 3.313104e-4 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 3.318403e-4 |
GO:0045445 | myoblast differentiation | 3.330755e-4 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 3.331128e-4 |
GO:0044085 | cellular component biogenesis | 3.391209e-4 |
GO:0009888 | tissue development | 3.391603e-4 |
GO:0048305 | immunoglobulin secretion | 3.434735e-4 |
GO:0006954 | inflammatory response | 3.436778e-4 |
GO:0033006 | regulation of mast cell activation involved in immune response | 3.454009e-4 |
GO:0003012 | muscle system process | 3.466170e-4 |
GO:0042424 | catecholamine catabolic process | 3.533372e-4 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 3.716585e-4 |
GO:0080135 | regulation of cellular response to stress | 3.757955e-4 |
GO:0048598 | embryonic morphogenesis | 3.759058e-4 |
GO:0050918 | positive chemotaxis | 3.815003e-4 |
GO:0002313 | mature B cell differentiation involved in immune response | 3.890799e-4 |
GO:0035089 | establishment of apical/basal cell polarity | 3.945266e-4 |
GO:0072573 | tolerance induction to lipopolysaccharide | 3.974057e-4 |
GO:2000349 | negative regulation of CD40 signaling pathway | 3.974057e-4 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.974057e-4 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 3.974057e-4 |
GO:0007099 | centriole replication | 3.974057e-4 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 3.974057e-4 |
GO:0002632 | negative regulation of granuloma formation | 3.974057e-4 |
GO:0032691 | negative regulation of interleukin-1 beta production | 4.057940e-4 |
GO:0019377 | glycolipid catabolic process | 4.181565e-4 |
GO:0006707 | cholesterol catabolic process | 4.186457e-4 |
GO:0060742 | epithelial cell differentiation involved in prostate gland development | 4.390970e-4 |
GO:0006694 | steroid biosynthetic process | 4.414329e-4 |
GO:0051098 | regulation of binding | 4.448210e-4 |
GO:0051049 | regulation of transport | 4.478589e-4 |
GO:0002687 | positive regulation of leukocyte migration | 4.483975e-4 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 4.560387e-4 |